Cargando…

Phenotype and frequency of STUB1 mutations: next-generation screenings in Caucasian ataxia and spastic paraplegia cohorts

BACKGROUND: Mutations in the gene STUB1, encoding the protein CHIP (C-terminus of HSC70-interacting protein), have recently been suggested as a cause of recessive ataxia based on the findings in few Chinese families. Here we aimed to investigate the phenotypic and genotypic spectrum of STUB1 mutatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Synofzik, Matthis, Schüle, Rebecca, Schulze, Martin, Gburek-Augustat, Janina, Schweizer, Roland, Schirmacher, Anja, Krägeloh-Mann, Ingeborg, Gonzalez, Michael, Young, Peter, Züchner, Stephan, Schöls, Ludger, Bauer, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021831/
https://www.ncbi.nlm.nih.gov/pubmed/24742043
http://dx.doi.org/10.1186/1750-1172-9-57
_version_ 1782316299472338944
author Synofzik, Matthis
Schüle, Rebecca
Schulze, Martin
Gburek-Augustat, Janina
Schweizer, Roland
Schirmacher, Anja
Krägeloh-Mann, Ingeborg
Gonzalez, Michael
Young, Peter
Züchner, Stephan
Schöls, Ludger
Bauer, Peter
author_facet Synofzik, Matthis
Schüle, Rebecca
Schulze, Martin
Gburek-Augustat, Janina
Schweizer, Roland
Schirmacher, Anja
Krägeloh-Mann, Ingeborg
Gonzalez, Michael
Young, Peter
Züchner, Stephan
Schöls, Ludger
Bauer, Peter
author_sort Synofzik, Matthis
collection PubMed
description BACKGROUND: Mutations in the gene STUB1, encoding the protein CHIP (C-terminus of HSC70-interacting protein), have recently been suggested as a cause of recessive ataxia based on the findings in few Chinese families. Here we aimed to investigate the phenotypic and genotypic spectrum of STUB1 mutations, and to assess their frequency in different Caucasian disease cohorts. METHODS: 300 subjects with degenerative ataxia (n = 167) or spastic paraplegia (n = 133) were screened for STUB1 variants by whole-exome-sequencing (n = 204) or shotgun-fragment-library-sequencing (n = 96). To control for the specificity of STUB1 variants, we screened an additional 1707 exomes from 891 index families with other neurological diseases. RESULTS: We identified 3 ataxia patients (3/167 = 1.8%) with 4 novel missense mutations in STUB1, including 3 mutations in its tetratricopeptide-repeat domain. All patients showed evidence of pyramidal tract damage. Cognitive impairment was present only in one and hypogonadism in none of them. Ataxia did not start before age 48 years in one subject. No recessive STUB1 variants were identified in families with other neurological diseases, demonstrating that STUB1 variants are not simply rare polymorphisms ubiquitous in neurodegenerative disease. CONCLUSIONS: STUB1-disease occurs also in Caucasian ataxia populations (1.8%). Our results expand the genotypic spectrum of STUB1-disease, showing that pathogenic mutations affect also the tetratricopeptide-repeat domain, thus providing clinical evidence for the functional importance of this domain. Moreover, they further delineate the phenotypic core features of STUB1-ataxia. Pyramidal tract damage is a common accompanying feature and can include lower limb spasticity, thus adding STUB1-ataxia to the differential diagnosis of “spastic ataxias”. However, STUB1 is rare in subjects with predominant spastic paraplegia (0/133). In contrast to previous reports, STUB1-ataxia can start even above age 40 years, and neither hypogonadism nor prominent cognitive impairment are obligatory features.
format Online
Article
Text
id pubmed-4021831
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40218312014-05-16 Phenotype and frequency of STUB1 mutations: next-generation screenings in Caucasian ataxia and spastic paraplegia cohorts Synofzik, Matthis Schüle, Rebecca Schulze, Martin Gburek-Augustat, Janina Schweizer, Roland Schirmacher, Anja Krägeloh-Mann, Ingeborg Gonzalez, Michael Young, Peter Züchner, Stephan Schöls, Ludger Bauer, Peter Orphanet J Rare Dis Research BACKGROUND: Mutations in the gene STUB1, encoding the protein CHIP (C-terminus of HSC70-interacting protein), have recently been suggested as a cause of recessive ataxia based on the findings in few Chinese families. Here we aimed to investigate the phenotypic and genotypic spectrum of STUB1 mutations, and to assess their frequency in different Caucasian disease cohorts. METHODS: 300 subjects with degenerative ataxia (n = 167) or spastic paraplegia (n = 133) were screened for STUB1 variants by whole-exome-sequencing (n = 204) or shotgun-fragment-library-sequencing (n = 96). To control for the specificity of STUB1 variants, we screened an additional 1707 exomes from 891 index families with other neurological diseases. RESULTS: We identified 3 ataxia patients (3/167 = 1.8%) with 4 novel missense mutations in STUB1, including 3 mutations in its tetratricopeptide-repeat domain. All patients showed evidence of pyramidal tract damage. Cognitive impairment was present only in one and hypogonadism in none of them. Ataxia did not start before age 48 years in one subject. No recessive STUB1 variants were identified in families with other neurological diseases, demonstrating that STUB1 variants are not simply rare polymorphisms ubiquitous in neurodegenerative disease. CONCLUSIONS: STUB1-disease occurs also in Caucasian ataxia populations (1.8%). Our results expand the genotypic spectrum of STUB1-disease, showing that pathogenic mutations affect also the tetratricopeptide-repeat domain, thus providing clinical evidence for the functional importance of this domain. Moreover, they further delineate the phenotypic core features of STUB1-ataxia. Pyramidal tract damage is a common accompanying feature and can include lower limb spasticity, thus adding STUB1-ataxia to the differential diagnosis of “spastic ataxias”. However, STUB1 is rare in subjects with predominant spastic paraplegia (0/133). In contrast to previous reports, STUB1-ataxia can start even above age 40 years, and neither hypogonadism nor prominent cognitive impairment are obligatory features. BioMed Central 2014-04-17 /pmc/articles/PMC4021831/ /pubmed/24742043 http://dx.doi.org/10.1186/1750-1172-9-57 Text en Copyright © 2014 Synofzik et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Synofzik, Matthis
Schüle, Rebecca
Schulze, Martin
Gburek-Augustat, Janina
Schweizer, Roland
Schirmacher, Anja
Krägeloh-Mann, Ingeborg
Gonzalez, Michael
Young, Peter
Züchner, Stephan
Schöls, Ludger
Bauer, Peter
Phenotype and frequency of STUB1 mutations: next-generation screenings in Caucasian ataxia and spastic paraplegia cohorts
title Phenotype and frequency of STUB1 mutations: next-generation screenings in Caucasian ataxia and spastic paraplegia cohorts
title_full Phenotype and frequency of STUB1 mutations: next-generation screenings in Caucasian ataxia and spastic paraplegia cohorts
title_fullStr Phenotype and frequency of STUB1 mutations: next-generation screenings in Caucasian ataxia and spastic paraplegia cohorts
title_full_unstemmed Phenotype and frequency of STUB1 mutations: next-generation screenings in Caucasian ataxia and spastic paraplegia cohorts
title_short Phenotype and frequency of STUB1 mutations: next-generation screenings in Caucasian ataxia and spastic paraplegia cohorts
title_sort phenotype and frequency of stub1 mutations: next-generation screenings in caucasian ataxia and spastic paraplegia cohorts
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021831/
https://www.ncbi.nlm.nih.gov/pubmed/24742043
http://dx.doi.org/10.1186/1750-1172-9-57
work_keys_str_mv AT synofzikmatthis phenotypeandfrequencyofstub1mutationsnextgenerationscreeningsincaucasianataxiaandspasticparaplegiacohorts
AT schulerebecca phenotypeandfrequencyofstub1mutationsnextgenerationscreeningsincaucasianataxiaandspasticparaplegiacohorts
AT schulzemartin phenotypeandfrequencyofstub1mutationsnextgenerationscreeningsincaucasianataxiaandspasticparaplegiacohorts
AT gburekaugustatjanina phenotypeandfrequencyofstub1mutationsnextgenerationscreeningsincaucasianataxiaandspasticparaplegiacohorts
AT schweizerroland phenotypeandfrequencyofstub1mutationsnextgenerationscreeningsincaucasianataxiaandspasticparaplegiacohorts
AT schirmacheranja phenotypeandfrequencyofstub1mutationsnextgenerationscreeningsincaucasianataxiaandspasticparaplegiacohorts
AT kragelohmanningeborg phenotypeandfrequencyofstub1mutationsnextgenerationscreeningsincaucasianataxiaandspasticparaplegiacohorts
AT gonzalezmichael phenotypeandfrequencyofstub1mutationsnextgenerationscreeningsincaucasianataxiaandspasticparaplegiacohorts
AT youngpeter phenotypeandfrequencyofstub1mutationsnextgenerationscreeningsincaucasianataxiaandspasticparaplegiacohorts
AT zuchnerstephan phenotypeandfrequencyofstub1mutationsnextgenerationscreeningsincaucasianataxiaandspasticparaplegiacohorts
AT scholsludger phenotypeandfrequencyofstub1mutationsnextgenerationscreeningsincaucasianataxiaandspasticparaplegiacohorts
AT bauerpeter phenotypeandfrequencyofstub1mutationsnextgenerationscreeningsincaucasianataxiaandspasticparaplegiacohorts